Veriosys Technologies, Inc.

Veriosys Technologies, Inc is a US-based medical technology company specializing in innovative skin cancer screening solutions. We revolutionize early detection through our DermataScan system, a non-invasive method utilizing DeepX OTD technology to analyze subsurface skin properties.

Our core mission is to improve patient outcomes by providing rapid, accurate, and accessible skin cancer diagnostics. We serve healthcare providers, including dermatologists and primary care physicians, offering a comprehensive solution for identifying suspicious lesions.

What differentiates us is our unique combination of optical transfer diagnosis, neural network analysis, and a secure telemedicine platform – DeepX – enabling remote assessment and integration with existing Electronic Medical Records (EMRs). We are committed to advancing skin cancer screening and saving lives, currently expanding our reach to include mobile screening environments in retirement communities and long-term care facilities.